Literature DB >> 8704105

Urinary excretion of aquaporin-2 in humans: a potential marker of collecting duct responsiveness to vasopressin.

S Elliot1, P Goldsmith, M Knepper, M Haughey, B Olson.   

Abstract

The vasopressin-sensitive water channel (aquaporin 2; AQP-2) mediates water transport across the apical plasma membrane of the renal collecting ducts and is excreted in human urine. This study presents the hypothesis that measurements of the AQP-2 excretion rate might be used as a marker of collecting-duct responsiveness to vasopressin, and therefore could be useful in the clinical evaluation of various water-balance disorders. This study presents information about the development of an antibody to human AQP-2, and measures the urinary excretion of AQP-2 by quantitative Western analysis. A standard curve of band densities was generated by using known quantities of the modified immunizing peptide to derive the amount of AQP-2 contained in aliquots of urine. AQP-2 urinary excretion changed with short-term alterations in hydration status produced either by water loading (76% decrease, P < 0.01) or by 3% sodium chloride (760% increase, P < 0.01). Steady-state 24-h urinary excretion of AQP-2 was 43 +/- 10 nmol/24 h (or 28.5 +/- 6.9 pmol/mg creatinine), and 20 +/- 6 nmol/24 h (or 18.3 +/- 7.9 pmol/mg creatinine) in men and women, respectively. Therefore, urinary AQP-2 excretion can be quantified by using Western analysis, and may serve as a marker of collecting-duct responsiveness to vasopressin in different physiologic settings.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8704105     DOI: 10.1681/ASN.V73403

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  27 in total

1.  Daily variance of urinary excretion of AQP2 determined by sandwich ELISA method.

Authors:  Sei Sasaki; Yasukazu Ohmoto; Toyoki Mori; Fusako Iwata; Masahiro Muraguchi
Journal:  Clin Exp Nephrol       Date:  2011-12-10       Impact factor: 2.801

2.  Urinary aquaporin-2 excretion during early human development.

Authors:  Marina Zelenina; Yanhong Li; Isabelle Glorieux; Catherine Arnaud; Christelle Cristini; Stéphane Decramer; Anita Aperia; Charlotte Casper
Journal:  Pediatr Nephrol       Date:  2006-06-01       Impact factor: 3.714

3.  The non-ligand binding beta-isoform of the human glucocorticoid receptor (hGR beta): tissue levels, mechanism of action, and potential physiologic role.

Authors:  M de Castro; S Elliot; T Kino; C Bamberger; M Karl; E Webster; G P Chrousos
Journal:  Mol Med       Date:  1996-09       Impact factor: 6.354

4.  Very delayed hyponatremia after surgery and radiotherapy for a pituitary macroadenoma.

Authors:  M Filippella; P Cappabianca; L M Cavallo; A Faggiano; G Lombardi; Divitiis E de; A Colao
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

5.  Changes in urinary excretion of water and sodium transporters during amiloride and bendroflumethiazide treatment.

Authors:  Janni M Jensen; Frank H Mose; Anna-Ewa O Kulik; Jesper N Bech; Robert A Fenton; Erling B Pedersen
Journal:  World J Nephrol       Date:  2015-07-06

6.  Urinary aquaporin-2 in children with acute pyelonephritis.

Authors:  Elena A Rodionova; Alla A Kuznetsova; Elena I Shakhmatova; Natalia Prutskova; Søren Nielsen; Ulla Holtbäck; Yuri Natochin; Marina Zelenina
Journal:  Pediatr Nephrol       Date:  2005-12-29       Impact factor: 3.714

7.  AQP2 in human urine is predominantly localized to exosomes with preserved water channel activities.

Authors:  Yuko Miyazawa; Saki Mikami; Keiko Yamamoto; Masaki Sakai; Tatsuya Saito; Tadashi Yamamoto; Kenichi Ishibashi; Sei Sasaki
Journal:  Clin Exp Nephrol       Date:  2018-02-02       Impact factor: 2.801

Review 8.  Vasopressin and the regulation of aquaporin-2.

Authors:  Justin L L Wilson; Carlos A Miranda; Mark A Knepper
Journal:  Clin Exp Nephrol       Date:  2013-04-13       Impact factor: 2.801

9.  Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites.

Authors:  Hiroyuki Nakanishi; Masayuki Kurosaki; Takanori Hosokawa; Yuka Takahashi; Jun Itakura; Shoko Suzuki; Yutaka Yasui; Nobuharu Tamaki; Natsuko Nakakuki; Hitomi Takada; Mayu Higuchi; Yasuyuki Komiyama; Tsubasa Yoshida; Kenta Takaura; Tsuguru Hayashi; Konomi Kuwabara; Sei Sasaki; Namiki Izumi
Journal:  J Gastroenterol       Date:  2015-11-26       Impact factor: 7.527

10.  Increased urinary excretion of aquaporin 2 in patients with liver cirrhosis.

Authors:  P Ivarsen; J Frøkiaer; N K Aagaard; E F Hansen; F Bendtsen; S Nielsen; H Vilstrup
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.